Patents
Patents for C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
01/2006
01/26/2006WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
01/26/2006US20060020022 Enantioselective separation method
01/26/2006CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
01/24/2006US6989453 Method of producing a cyclohexenone oxime ether lithium salt, products which can be obtained using this method, the use thereof and corresponding plant protection agents
01/19/2006US20060014803 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
01/18/2006EP1615915A1 Phenacyl 2-hydroxy-3-diaminoalkanes
01/18/2006EP1615905A2 Benzopyran compounds useful for treating inflammatory conditions
01/18/2006EP1615892A2 Benzamide 2-hydroxy-3-diaminoalkanes
01/18/2006CN1723206A High specificity anticancer pharmacological drug system, drug synthesis, and drug development process
01/12/2006WO2005066115A3 Disubstituted chalcone oximes having rarϝ retinoid receptor antagonist activity
01/11/2006EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai
01/11/2006CN1235898C Cyclohexenondioxothio chromanoyl derivatives
01/03/2006US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis
01/03/2006CA2093577C Alkyl or alkoxy substituted s-heterocyclic retinoids
12/2005
12/29/2005WO2005123713A1 Process for the preparation of disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups
12/28/2005EP1610126A1 A system for determining the electrical potential across a membrane
12/22/2005WO2005120439A1 Photopolymerisable dental composition
12/20/2005CA2302412C Aminoalkylphenol derivatives and related compounds
12/15/2005WO2005087751A3 Substituted hydroxyethylamine aspartyl protease inhibitors
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/06/2005CA2289599C Substituted heterocyclic compounds, method for preparing and compositions containing same
12/06/2005CA2173257C Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
12/01/2005US20050267199 2-Amino- and 2-thio- substituted 1,3-diaminopropanes
11/2005
11/30/2005EP1599461A1 Thiolactones
11/29/2005CA2070799C Thioxanthenone antitumor agents
11/24/2005US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/23/2005CN1701067A Thioxanthone derivatives, and their use as cationic photoinitiators
11/23/2005CN1228337C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
11/17/2005WO2005108338A1 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
11/16/2005EP1594867A2 Phenylacetamides and their use as glucokinase modulators
11/16/2005EP1317426B1 Beta-thio-amino acids
11/16/2005EP0834074B2 Detection of transmembrane potentials by optical methods
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/15/2005CA2070120C Thioxanthenone antitumor agents
11/10/2005WO2005105770A2 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/10/2005WO2005095326A3 2-amino- and 2-thio-substituted 1,3-diaminopropanes
11/10/2005WO2001009093A8 Benzenamine derivatives as anti-coagulants
11/10/2005CA2562176A1 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
11/09/2005CN1694700A Non-nucleoside reverse transcriptase inhibitors
11/09/2005CN1226274C Aromatic tetramine monomer and aromatic tetramine chydrochloride and their preparation process
11/08/2005US6963002 Process for the preparation of 4,4-dimethyl-6-ethynylthiochroman
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/01/2005US6960668 Process for the production of substituted thioxanthones
10/2005
10/27/2005WO2005100311A1 Bicyclic aromatic sulfinyl derivatives
10/27/2005WO2005066115A8 Disubstituted chalcone oximes having rarϝ retinoid receptor antagonist activity
10/27/2005US20050240035 polymerase inhibitors such as -1-(5-Cyano-pyridin-2-yl)-3-(1,1a,2,7b-tetrahydro-cyclopropa[c]chromene-1-yl)-urea, used as antiviral agents
10/27/2005US20050240029 preparation of intermediates for tazarotene using a Vilsmeier Haack reaction; without the use of lithium diisopropylamide which is moisture sensitive, expensive, pyrophoric, and difficult to handle on a commercial scale, or diethyl chlorophosphate, which is highly toxic and corrosive
10/27/2005US20050240020 Functional fluorescent dyes
10/27/2005US20050239836 Substituted hydroxyethylamine aspartyl protease inhibitors
10/27/2005CA2561555A1 Bicyclic aromatic sulfinyl derivatives
10/25/2005CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2005CA2120782C Thioxanthenone antitumor agents
10/20/2005WO2005066116A8 Disubstituted chalcone oximes as selective agonists of rarϝ retinoid receptors
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050233253 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether
10/19/2005EP1586561A1 Bicyclic aromatic sulfinyl derivatives
10/13/2005WO2005095326A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/13/2005US20050228040 Bicyclic aromatic sulfinyl derivatives
10/13/2005US20050227967 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
10/13/2005CA2560773A1 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/12/2005CN1681891A Functional fluorescent dyes
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005WO2004072031A8 Phenylacetamides and their use as glucokinase modulators
10/05/2005EP1581513A1 Multifunctional cationic photoinitiators, their preparation and use
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
09/2005
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/27/2005US6949678 For resist applications; thermostability, storage stability
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/22/2005WO2005087751A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005CA2558034A1 Substituted hydroxyethylamine aspartyl protease inhibitors
09/20/2005US6946467 Serine protease inhibitors
09/15/2005WO2004029019A8 Compounds for the treatment of alzheimer’s disease
09/14/2005EP1572676A2 High specificity anticancer pharmacological drug system, drug synthesis, and drug development process
09/14/2005EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
09/14/2005CN1668608A Heterodiamondoids
09/09/2005WO2005058867A8 Benzothiophene-and thiochromene containing phenethanolamine derivatives for the treatment of respiratory disorders
09/01/2005WO2005080322A1 Fluorene derivative
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050191567 Oxime ester photoinitiators
09/01/2005CA2537079A1 Fluorene derivative
08/2005
08/31/2005EP1567515A2 Novel lapachone compounds and methods of use thereof
08/31/2005CN1662559A Polymeric photoinitiators
08/31/2005CN1660837A Light mitiator of thioxanthone-2-carboxylic ester
08/30/2005US6936611 Serine protease inhibitors
08/25/2005US20050187110 Novel herbicides
08/24/2005EP1565443A2 Acetyl 2-hydroxy-1,3 diaminoalkanes
08/24/2005EP1565428A1 Substituted ureas and carbamates
08/18/2005US20050182096 Haloalkyl containing compounds as cysteine protease inhibitors
08/18/2005US20050182040 Benzamide derivatives
08/17/2005EP1280757B1 New gamma selective retinoids
08/16/2005US6930200 Mono-and di-substituted alpha-amino acid derivatives useful as raw materials for pharmaceutical and agro-chemical products
08/16/2005US6930184 Functional fluorescent dyes
08/11/2005WO2005073206A1 Selective estrogen receptor modulators
08/11/2005WO2005073204A1 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 48